SG Americas Securities’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-80,000
Closed -$224K 3169
2022
Q3
$224K Buy
+80,000
New +$4.11M ﹤0.01% 2224

Other funds holding GH

SG Americas Securities's GH Position: Q1 2026 in Review

SG Americas Securities increased its Guardant Health (GH) stake by 30% in Q1 2026, buying an estimated $522K and bringing the position to 22,244 shares worth $2.06M. The position accounts for ﹤0.01% of the portfolio, ranked #1383.

SG Americas Securities first reported a position in GH in Q1 2019 and has held it in 24 quarters since. The position peaked at $8.85M in Q3 2021. 482 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • SG Americas Securities held 22,244 shares of Guardant Health worth $2.06M as of Q1 2026.
  • SG Americas Securities bought 5,197 Guardant Health shares in Q1 2026, an estimated $522K.
  • Guardant Health made up ﹤0.01% of SG Americas Securities's portfolio in Q1 2026, its #1383 holding.
  • SG Americas Securities first reported a position in Guardant Health in Q1 2019 and has held it in 24 quarters since.
  • SG Americas Securities's Guardant Health position peaked at $8.85M in Q3 2021.
  • 482 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.